Project 2

eConsent in Clinical Trials

The purpose of this CT:IQ project was to investigate barriers to uptake of eConsent within the Australian clinical trial context and create actionable insights to support increased adoption of the technology. In addition, gaining a greater understanding of the current use and adoption of eConsent across the Australian clinical trials landscape, including stakeholder opinions about the benefits, risks and critical success factors for eConsent implementation, provides information for those seeking to trial and ultimately implement eConsent.

Read the full report